Table 1:
n | % | ||
---|---|---|---|
Total | 242 | ||
Individuals | Male | 79 | 32.6 |
Female | 163 | 66.9 | |
Employee | 134 | 55.4 | |
Hospitalized | 87 | 36 | |
Clinical presentation | Symptomatic | 205 | 84.7 |
Presymptomatic | 21 | 8.7 | |
Asymptomatic | 16 | 6.6 | |
Reason for hospitalization | COVID-19 | 54 | 62.1 |
Other | 33 | 37.9 | |
Patient outcome | Deceased | 23 | 9.5 |
Survival or unknown outcome | 219 | 90.5 | |
Age | 0–30 | 27 | 11.2 |
31–60 | 134 | 55.3 | |
61–104 | 81 | 33.5 | |
Charlson comorbidity index | 0* | 187 | 77.3 |
1 | 7 | 2.9 | |
2 | 26 | 10.7 | |
3 | 16 | 6.6 | |
4+ | 6 | 2.5 |
Includes individuals with no reported comorbidities